Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carl Goldfischer currently holds 36,000 shares of MAP Pharmaceuticals, Inc. (MAPP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carl Goldfischer has been a net seller of MAPP stock. They have purchased $18.6M and sold $43.5M worth of shares.
Carl Goldfischer's most recent insider trade was on Jun 20, 2024, when they sold 36,000 shares at $0.00 per share.
Carl Goldfischer serves as Executive at MAP Pharmaceuticals, Inc. (MAPP). They have executed 98 insider transactions totaling $62.2M over their tenure at the company.
Carl Goldfischer holds the position of Executive at MAP Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Carl Goldfischer has shown a selling trading pattern, with $18.6M in total purchases and $43.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carl Goldfischer was on Feb 10, 2014, when they sold $13.4M worth of EPZM shares. This transaction involved 457,940 shares at $29.25 per share.
Carl Goldfischer currently owns 36,000 shares of MAP Pharmaceuticals, Inc. (MAPP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carl Goldfischer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carl Goldfischer has 98 Form 4 filings on record as an insider at MAP Pharmaceuticals, Inc..
Set alerts for Carl Goldfischer and 40,000+ other insiders.